|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - KalVista Pharmaceuticals Inc. (KALV)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-03-14 Sale |
2019-03-15 8:03 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
3,000 | $30.16 | $90,484 | 268,510 (Direct) |
View |
| 2019-03-04 Sale |
2019-03-06 09:05 am |
KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner |
75,710 | $22.96 | $1,738,476 | 2,223,015 (Direct) |
View |
| 2019-02-19 Sale |
2019-02-21 2:35 pm |
KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner |
214,198 | $20.55 | $4,401,353 | 2,455,569 (Direct) |
View |
| 2019-01-25 Sale |
2019-01-29 6:53 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
5,453 | $17.06 | $93,015 | 109,455 (Direct) |
View |
| 2019-01-22 Sale |
2019-01-24 7:48 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
1,902 | $17.01 | $32,344 | 115,508 (Direct) |
View |
| 2019-01-16 Sale |
2019-01-18 5:42 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
4,000 | $19.55 | $78,210 | 106,334 (Direct) |
View |
| 2019-01-14 Sale |
2019-01-16 6:25 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
10,000 | $19.33 | $193,328 | 272,411 (Direct) |
View |
| 2019-01-03 Sale |
2019-01-07 5:12 pm |
KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner |
4,299 | $20.25 | $87,073 | 2,476,008 (Direct) |
View |
| 2018-12-28 Sale |
2019-01-02 7:10 pm |
KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner |
29,352 | $20.01 | $587,242 | 2,502,571 (Direct) |
View |
| 2018-12-19 Sale |
2018-12-21 4:19 pm |
KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner |
2,136 | $20.02 | $42,758 | 2,506,202 (Direct) |
View |
| 2018-09-10 Purchase |
2018-09-12 7:16 pm |
KalVista Pharmaceuticals Inc. | KALV | ORONSKY ARNOLD L Director |
58,824 | $17 | $1,000,008 | 388,766 (Indirect) |
View |
| 2018-09-10 Purchase |
2018-09-12 7:11 pm |
KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director |
1,058,824 | $17 | $18,000,008 | 1,359,149 (Indirect) |
View |
| 2017-10-12 Purchase |
2017-10-19 8:29 pm |
KalVista Pharmaceuticals Inc. | KALV | ALDRICH RICHARD Director |
565,065 | $8.613 | $4,866,961 | 934,484 (Indirect) |
View |
| 2017-10-12 Purchase |
2017-10-16 4:32 pm |
KalVista Pharmaceuticals Inc. | KALV | RA CAPITAL MANAGEMENT LLC Kolchinsky Peter Director, 10% Owner |
850,000 | $8.5 | $7,225,000 | 1,441,070 (Indirect) |
View |
| 2017-10-12 Purchase |
2017-10-16 4:31 pm |
KalVista Pharmaceuticals Inc. | KALV | Shah Rajeev M. Director, 10% Owner |
850,000 | $8.5 | $7,225,000 | 1,441,070 (Indirect) |
View |
| 2017-10-10 Sale |
2017-10-12 5:21 pm |
KalVista Pharmaceuticals Inc. | KALV | Novo Holdings A/S 10% Owner |
2,725,283 | $9.64 | $26,271,182 | 2,311,927 (Direct) |
View |
| 2017-09-13 Sale(A) |
2017-09-18 7:04 pm |
KalVista Pharmaceuticals Inc. | KALV | Novo Holdings A/S 10% Owner |
176,644 | $7.212 | $1,273,956 | 2,876,027 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-02-01 Option Award |
2019-02-05 5:41 pm |
N/A 2029-01-31 |
KalVista Pharmaceuticals Inc. | KALV | Pereira Brian JG Director |
14,000 | $17.95 | 14,000 (Direct) |
View |
| 2019-01-25 Exercise |
2019-01-29 6:53 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
5,453 | $0.0043 | 109,455 (Direct) |
View |
| 2019-01-25 Exercise |
2019-01-29 6:53 pm |
N/A 2026-03-30 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
5,453 | $0.0043 | 109,455 (Direct) |
View |
| 2019-01-22 Exercise |
2019-01-24 7:48 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
1,302 | $0.0043 | 115,508 (Direct) |
View |
| 2019-01-22 Exercise |
2019-01-24 7:48 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
600 | $0.0043 | 115,508 (Direct) |
View |
| 2019-01-22 Exercise |
2019-01-24 7:48 pm |
N/A 2026-03-30 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
1,302 | $0.0043 | 115,508 (Direct) |
View |
| 2019-01-22 Exercise |
2019-01-24 7:48 pm |
N/A 2026-03-30 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
600 | $0.0043 | 115,508 (Direct) |
View |
| 2016-11-21 Option Award |
2019-01-24 7:44 pm |
N/A 2026-03-30 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
116,810 | $0.0043 | 116,810 (Direct) |
View |
| 2018-10-03 Option Award |
2018-10-05 6:08 pm |
N/A 2028-10-02 |
KalVista Pharmaceuticals Inc. | KALV | Unkart Edward W Director |
7,000 | $22.65 | 7,000 (Direct) |
View |
| 2018-10-03 Option Award |
2018-10-05 6:07 pm |
N/A 2028-10-02 |
KalVista Pharmaceuticals Inc. | KALV | ORONSKY ARNOLD L Director |
7,000 | $22.65 | 7,000 (Direct) |
View |
| 2018-10-03 Option Award |
2018-10-05 6:05 pm |
N/A 2028-10-02 |
KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director |
7,000 | $22.65 | 7,000 (Direct) |
View |
| 2018-10-03 Option Award |
2018-10-05 6:03 pm |
N/A 2028-10-02 |
KalVista Pharmaceuticals Inc. | KALV | ALDRICH RICHARD Director |
7,000 | $22.65 | 7,000 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 7:35 pm |
N/A 2028-09-17 |
KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP |
20,700 | $16.08 | 20,700 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 7:33 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
12,500 | $0 | 110,534 (Direct) |
View |
| 2018-09-18 Tax Withholding |
2018-09-20 7:33 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
2,500 | $17.05 | 110,534 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 7:33 pm |
N/A 2028-09-17 |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
52,600 | $16.08 | 110,534 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 7:31 pm |
N/A 2028-09-17 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
52,600 | $16.08 | 52,600 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 7:29 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO |
32,500 | $0 | 52,600 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 7:29 pm |
N/A 2028-09-17 |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO |
52,600 | $16.08 | 52,600 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 7:26 pm |
N/A 2028-09-17 |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
150,000 | $16.08 | 150,000 (Direct) |
View |
| 2018-06-04 Option Award |
2018-06-06 5:15 pm |
N/A 2028-06-03 |
KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP |
20,700 | $8.21 | 20,700 (Direct) |
View |
| 2018-06-04 Option Award |
2018-06-06 5:11 pm |
N/A 2028-06-03 |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
51,800 | $8.21 | 51,800 (Direct) |
View |
| 2018-06-04 Option Award |
2018-06-06 5:09 pm |
N/A 2028-06-03 |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO |
71,700 | $8.21 | 71,700 (Direct) |
View |
| 2018-06-04 Option Award |
2018-06-06 5:06 pm |
N/A 2028-06-03 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
53,500 | $8.21 | 53,500 (Direct) |
View |
| 2018-06-04 Option Award |
2018-06-06 5:02 pm |
N/A 2028-06-03 |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
130,800 | $8.21 | 130,800 (Direct) |
View |
| 2017-09-27 Option Award |
2017-09-29 8:17 pm |
N/A 2027-09-26 |
KalVista Pharmaceuticals Inc. | KALV | Resnick Joshua Director |
6,000 | $6.71 | 6,000 (Direct) |
View |
| 2017-09-27 Option Award |
2017-09-29 7:19 pm |
N/A 2027-09-26 |
KalVista Pharmaceuticals Inc. | KALV | Unkart Edward W Director |
6,000 | $6.71 | 6,000 (Direct) |
View |
| 2017-09-27 Option Award |
2017-09-29 7:18 pm |
N/A 2027-09-26 |
KalVista Pharmaceuticals Inc. | KALV | Shah Rajeev M. Director |
6,000 | $6.71 | 6,000 (Direct) |
View |
| 2017-09-27 Option Award |
2017-09-29 7:16 pm |
N/A 2027-09-26 |
KalVista Pharmaceuticals Inc. | KALV | ORONSKY ARNOLD L Director |
6,000 | $6.71 | 6,000 (Direct) |
View |
| 2017-09-27 Option Award |
2017-09-29 7:15 pm |
N/A 2027-09-26 |
KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director |
6,000 | $6.71 | 6,000 (Direct) |
View |
| 2017-09-27 Option Award |
2017-09-29 7:13 pm |
N/A 2027-09-26 |
KalVista Pharmaceuticals Inc. | KALV | ALDRICH RICHARD Director |
6,000 | $6.71 | 6,000 (Direct) |
View |
| 2017-09-27 Option Award |
2017-09-29 4:30 pm |
N/A 2027-09-26 |
KalVista Pharmaceuticals Inc. | KALV | RA CAPITAL MANAGEMENT LLC Kolchinsky Peter Director |
6,000 | $6.71 | 6,000 (Indirect) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Tue, 19 Mar 2019 12:11:36 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |